1 - 1 of
1 for companies in category
Delivery in
Denmark:
The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome Pharma very competitive in a commercially attractive and dynamic anticancer market, where drug delivery systems will gain increasing importance over the coming years.
[First Page] [Prev] Showing page 1 of 1 pages [Next] [Last Page]
